Bernhard Nieswandt Selected Research

platelet membrane glycoprotein VI

10/2021	Targeting platelet glycoprotein VI attenuates progressive ischemic brain damage before recanalization during middle cerebral artery occlusion in mice.
1/2020	Platelet glycoprotein VI promotes metastasis through interaction with cancer cell-derived galectin-3.
9/2014	Analysis of the role of von Willebrand factor, platelet glycoprotein VI-, and α2β1-mediated collagen binding in thrombus formation.
11/2012	Platelet GPVI: a target for antithrombotic therapy?!
7/2010	Roles of platelet STIM1 and Orai1 in glycoprotein VI- and thrombin-dependent procoagulant activity and thrombus formation.
6/2005	Human atheromatous plaques stimulate thrombus formation by activating platelet glycoprotein VI.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bernhard Nieswandt Research Topics

Disease

88	Thrombosis (Thrombus) 12/2022 - 06/2002
35	Stroke (Strokes) 07/2022 - 03/2006
30	Inflammation (Inflammations) 01/2022 - 02/2006
21	Hemorrhage 01/2021 - 03/2003
18	Ischemic Stroke 01/2022 - 06/2005
13	Infarction (Infarctions) 01/2022 - 05/2007
10	Thrombocytopenia (Thrombopenia) 01/2022 - 03/2003
10	Vascular System Injuries 04/2019 - 01/2003
9	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 10/2021 - 05/2007
9	Myocardial Infarction 11/2020 - 06/2005
8	Brain Ischemia (Cerebral Ischemia) 05/2014 - 03/2006
7	Neoplasms (Cancer) 01/2020 - 02/2010
6	Reperfusion Injury 01/2021 - 04/2007
6	Atherosclerosis 01/2017 - 06/2009
5	Ischemia 11/2019 - 10/2012
5	Brain Infarction 09/2013 - 04/2008
4	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 09/2021 - 02/2010
4	Cerebral Infarction 02/2021 - 05/2007
4	Neoplasm Metastasis (Metastasis) 01/2020 - 02/2010
4	Pulmonary Embolism 04/2015 - 07/2006
3	Neuroinflammatory Diseases 09/2021 - 01/2016
3	Myocardial Ischemia (Ischemic Heart Diseases) 01/2021 - 05/2015
3	Rupture 01/2017 - 06/2005
3	Atherosclerotic Plaque (Atheroma) 01/2012 - 06/2005
3	Cardiovascular Diseases (Cardiovascular Disease) 12/2005 - 11/2004
2	Infections 04/2021 - 05/2014
2	Pneumonia (Pneumonitis) 01/2018 - 12/2009
2	Cerebral Hemorrhage 01/2017 - 12/2015
2	Hyperalgesia 01/2017 - 07/2014
2	Scott Syndrome 11/2016 - 02/2016
2	Thromboinflammation 11/2016 - 05/2015
2	Body Weight (Weight, Body) 01/2016 - 09/2010

Drug/Important Bio-Agent (IBA)

35	Glycoproteins (Glycoprotein)IBA 12/2022 - 04/2003
33	CollagenIBA 03/2022 - 01/2003
16	IntegrinsIBA 01/2022 - 12/2003
15	Proteins (Proteins, Gene)FDA Link 03/2022 - 02/2010
14	Factor XII (Hageman Factor)IBA 11/2021 - 07/2005
12	Collagen ReceptorsIBA 12/2022 - 11/2004
11	Hemostatics (Antihemorrhagics)IBA 12/2019 - 07/2003
10	FibrinIBA 03/2022 - 06/2005
9	Thrombin FDA Link 01/2022 - 07/2004
8	AntibodiesIBA 01/2020 - 03/2003
8	von Willebrand FactorIBA 01/2019 - 04/2009
6	Platelet Membrane GlycoproteinsIBA 01/2022 - 07/2004
6	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022 - 12/2005
6	Peptide Hydrolases (Proteases)FDA Link 12/2021 - 02/2006
6	platelet membrane glycoprotein VIIBA 10/2021 - 06/2005
6	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 09/2021 - 11/2003
6	Immunoglobulin G (IgG)IBA 02/2021 - 03/2003
6	AntigensIBA 02/2021 - 03/2003
6	CalciumIBA 11/2019 - 07/2008
6	LigandsIBA 01/2019 - 12/2007
5	CytokinesIBA 01/2021 - 12/2009
4	Adenosine Diphosphate (ADP)IBA 07/2022 - 04/2003
4	Thromboplastin (Tissue Factor)IBA 12/2021 - 06/2005
4	C-Type Lectins (C-Type Lectin)IBA 04/2021 - 05/2013
4	Pharmaceutical PreparationsIBA 04/2021 - 08/2011
4	Immunoglobulin Fab FragmentsIBA 11/2017 - 05/2007
4	Monoclonal AntibodiesIBA 04/2016 - 08/2006
4	Phospholipases (Phospholipase)IBA 01/2016 - 12/2005
4	EnzymesIBA 01/2016 - 01/2012
4	von Willebrand factor receptor (VWF receptor)IBA 01/2014 - 12/2005
3	Fibronectins (Fibronectin)IBA 03/2022 - 09/2010
3	Biomarkers (Surrogate Marker)IBA 02/2022 - 01/2014
3	Clopidogrel (Plavix)FDA Link 01/2022 - 01/2009
3	adhesion receptorIBA 02/2021 - 04/2009
3	Therapeutic UsesIBA 02/2021 - 06/2015
3	Fibrinogen (Factor I)FDA Link 01/2019 - 01/2012
3	Antigen-Antibody Complex (Immune Complex)IBA 01/2018 - 01/2014
3	Apolipoproteins E (ApoE)IBA 01/2017 - 09/2010
3	triphenyltetrazoliumIBA 04/2016 - 05/2007
3	PhosphatidylserinesIBA 02/2016 - 07/2004
3	1-dodecylpyridoxal (PLD)IBA 01/2016 - 11/2012
3	Epinephrine (Adrenaline)FDA LinkGeneric 04/2015 - 07/2005
3	phospholipase D1IBA 08/2014 - 01/2010
3	LipidsIBA 09/2013 - 06/2005
3	Protein Isoforms (Isoforms)IBA 09/2013 - 03/2007
3	CoagulantsIBA 07/2013 - 09/2011
3	P-SelectinIBA 02/2010 - 07/2006
3	Integrin alpha2beta1IBA 11/2007 - 04/2003
3	Platelet Glycoprotein GPIIb-IIIa ComplexIBA 07/2006 - 06/2002
2	Actins (F Actin)IBA 12/2022 - 01/2020
2	Laminin (Merosin)IBA 03/2022 - 01/2019
2	ChemokinesIBA 01/2022 - 01/2020
2	GTP-Binding Proteins (G-Protein)IBA 01/2022 - 03/2009
2	Syk KinaseIBA 12/2021 - 01/2021
2	InterleukinsIBA 01/2021 - 05/2014
2	AnticoagulantsIBA 01/2021 - 11/2008
2	Carrier Proteins (Binding Protein)IBA 01/2020 - 10/2012
2	Calcium Channels (Calcium Channel)IBA 11/2019 - 04/2016
2	Glucose (Dextrose)FDA LinkGeneric 11/2019 - 01/2016
2	Serotonin (5 Hydroxytryptamine)IBA 01/2018 - 01/2016
2	ThromboxanesIBA 01/2017 - 01/2014
2	ZymosanIBA 01/2017 - 07/2014
2	Stromal Interaction Molecule 1IBA 04/2016 - 08/2011
2	Human Serum Albumin FDA LinkGeneric 01/2016 - 04/2010
2	Factor XIIa (Coagulation Factor XIIa)IBA 01/2016 - 01/2016

Therapy/Procedure

10	Therapeutics 01/2022 - 11/2004
5	Thrombectomy 01/2022 - 10/2018
2	Ligation 01/2021 - 04/2016